Weizhi Zhang

Wenzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

MT2A facilitates the malignant progression of clear cell renal cell carcinoma by activating the TFAP2A/YAP axis via histone lactylation.

MT2A facilitates the malignant progression of clear cell renal cell carcinoma by activating the TFAP2A/YAP axis via histone lactylation.

Journal: Chemico-biological interactions

Published: March 14, 2026

Ginsenoside Rk1 suppresses the epithelial-mesenchymal transition of hepatic stellate cells via PFKFB2-mediated aerobic glycolysis.

Ginsenoside Rk1 suppresses the epithelial-mesenchymal transition of hepatic stellate cells via PFKFB2-mediated aerobic glycolysis.

Journal: Chemico-biological interactions

Published: August 29, 2025

Baicalein facilitates hepatic stellate cell ferroptosis via the DNMT1/SCARA5/GPX4 axis.

Baicalein facilitates hepatic stellate cell ferroptosis via the DNMT1/SCARA5/GPX4 axis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: August 21, 2025

Identification and Experimental Validation of Prognostic Signature and Peroxisome-Related Key Genes in Clear Cell Renal Cell Carcinoma.

Identification and Experimental Validation of Prognostic Signature and Peroxisome-Related Key Genes in Clear Cell Renal Cell Carcinoma.

Journal: International journal of general medicine

Published: December 19, 2024

The role of lncRNA-ZFAS1 in liver fibrosis: insights into the miR-1953/TAZ axis.

The role of lncRNA-ZFAS1 in liver fibrosis: insights into the miR-1953/TAZ axis.

Journal: Molecular and cellular biochemistry

Published: December 09, 2024

Comprehensive analysis of the role of NEDD4 in pan-cancer and experimental verification of its role in KIRC progression.

Comprehensive analysis of the role of NEDD4 in pan-cancer and experimental verification of its role in KIRC progression.

Journal: Discover oncology

Published: December 07, 2024

Exploration of ANKRD27 as an immune-related prognostic factor in pan-cancer and hepatocellular carcinoma.

Exploration of ANKRD27 as an immune-related prognostic factor in pan-cancer and hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: October 14, 2024

ALOX15-Driven Ferroptosis: The key target in Dihydrotanshinone I's epigenetic Battle in hepatic stellate cells against liver fibrosis.

ALOX15-Driven Ferroptosis: The key target in Dihydrotanshinone I's epigenetic Battle in hepatic stellate cells against liver fibrosis.

Journal: International immunopharmacology

Published: October 11, 2024

Unveiling the role of Pafah1b3 in liver fibrosis: A novel mechanism revealed.

Unveiling the role of Pafah1b3 in liver fibrosis: A novel mechanism revealed.

Journal: Journal of pharmaceutical analysis

Published: August 20, 2024

ATF3-mediated transactivation of CXCL14 in HSCs during liver fibrosis.

ATF3-mediated transactivation of CXCL14 in HSCs during liver fibrosis.

Journal: Clinical and translational medicine

Published: July 27, 2024

Polyphyllin VII promotes hepatic stellate cell ferroptosis via the HIC1/CX3CL1/GPX4 axis.

Polyphyllin VII promotes hepatic stellate cell ferroptosis via the HIC1/CX3CL1/GPX4 axis.

Journal: Journal of pharmaceutical analysis

Published: July 23, 2024

The IGF2BP3/Notch/Jag1 pathway: A key regulator of hepatic stellate cell ferroptosis in liver fibrosis.

The IGF2BP3/Notch/Jag1 pathway: A key regulator of hepatic stellate cell ferroptosis in liver fibrosis.

Journal: Clinical and translational medicine

Published: May 20, 2024

Showing 1-12 of 16

Last Updated: 09/26/2026